Purity Biologics
Home
OneAI
Biosimilars
Complex-Drugs
QUANTUM
About
Purity Biologics
Home
OneAI
Biosimilars
Complex-Drugs
QUANTUM
About
More
  • Home
  • OneAI
  • Biosimilars
  • Complex-Drugs
  • QUANTUM
  • About
  • Home
  • OneAI
  • Biosimilars
  • Complex-Drugs
  • QUANTUM
  • About

About Purity Biologics

 

Purity Biologics is a biotechnology company developing and commercializing advanced drug-quality technologies through two complementary divisions: OneAI, our biospectral imaging and AI platform, and SIQbio, our quantum technology development division.


OneAI delivers rapid, non-contact biospectral characterization to measure, compare, and improve biologic quality. SIQbio explores next-generation quantum sensing, imaging, and AI/SI technologies for advanced drug analysis.


 Purity Biologics engages biopharmaceutical companies, government agencies, research institutions, and technology partners to advance development, validation, and commercialization. 

Tip of the Spear

David Lamoureux

Maurizio Cattaneo, PhD

Maurizio Cattaneo, PhD

Co-founder & CEO

 Commercialization • Strategy • Partnerships 

Maurizio Cattaneo, PhD

Maurizio Cattaneo, PhD

Maurizio Cattaneo, PhD

 Co-founder & Lead Scientist
Biochemist • Biospectral Imaging • OneAI™ Development 

Matteo Forgione, P.E.

Maurizio Cattaneo, PhD

Matteo Forgione, P.E.

 Co-founder & CTO
Engineering, Imaging Systems • AI Integration • OneAI™ Development 

Remco Spanjaard, PhD

Remco Spanjaard, PhD

Matteo Forgione, P.E.

 Biological & Translational Strategy
Biologics Development • Strategic Partnerships • Regulatory

Paul Celi

Remco Spanjaard, PhD

Paul Celi

 Commercial & Strategic Partnerships
Biopharma • Business Development • Industry Partnerships 

How can we help?


contact us

Copyright © 2026 Purity Biologics Inc - All Rights Reserved.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept